Home › Funds › Point72 Asset Management › XFOR
Point72 Asset Management position in XFOR
X4 PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)41.07K sh
Reported value held$191.81K
Portfolio Weight0.00%
First reportedQ2 2025
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 21.67K | $41.17K | New |
| Q3 2025 | 21.67K | $74.10K | Hold |
| Q4 2025 | 808.15K | $3.23M | Add |
| Q2 2026 | 41.07K | $191.81K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding XFOR
- Morgan Stanley 9.46M sh · $44.18M · Q2 2026
- Fidelity Management & Research (FMR) 8.32M sh · $38.86M · Q2 2026
- BlackRock Inc 5.55M sh · $25.94M · Q2 2026
- Vanguard Group 3.42M sh · $13.69M · Q4 2025
- Geode Capital Management 2.10M sh · $9.80M · Q2 2026
- Goldman Sachs Group 916.54K sh · $4.28M · Q2 2026
- Northern Trust Corp 652.85K sh · $3.05M · Q2 2026
- Charles Schwab Investment Management 263.26K sh · $1.23M · Q2 2026
- BNY Mellon 196.34K sh · $916.91K · Q2 2026
- Invesco Ltd 96.77K sh · $451.93K · Q2 2026
- Deutsche Bank AG 78.89K sh · $368.39K · Q2 2026
- Citigroup Inc 70.11K sh · $327.42K · Q2 2026